Back to Search Start Over

Reflections on the cost of 'low-cost' whole genome sequencing: framing the health policy debate.

Authors :
Timothy Caulfield
Jim Evans
Amy McGuire
Christopher McCabe
Tania Bubela
Robert Cook-Deegan
Jennifer Fishman
Stuart Hogarth
Fiona A Miller
Vardit Ravitsky
Barbara Biesecker
Pascal Borry
Mildred K Cho
June C Carroll
Holly Etchegary
Yann Joly
Kazuto Kato
Sandra Soo-Jin Lee
Karen Rothenberg
Pamela Sankar
Michael J Szego
Pilar Ossorio
Daryl Pullman
Francois Rousseau
Wendy J Ungar
Brenda Wilson
Source :
PLoS Biology, Vol 11, Iss 11, p e1001699 (2013)
Publication Year :
2013
Publisher :
Public Library of Science (PLoS), 2013.

Abstract

The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy.

Subjects

Subjects :
Biology (General)
QH301-705.5

Details

Language :
English
ISSN :
15449173 and 15457885
Volume :
11
Issue :
11
Database :
Directory of Open Access Journals
Journal :
PLoS Biology
Publication Type :
Academic Journal
Accession number :
edsdoj.7dc7b64fbc41bd87b9096edfe82feb
Document Type :
article
Full Text :
https://doi.org/10.1371/journal.pbio.1001699